Literature DB >> 28499284

Emergence and Spread of Neisseria gonorrhoeae Isolates With Decreased Susceptibility to Extended-Spectrum Cephalosporins in Argentina, 2009 to 2013.

Ricardo Gianecini1, Maria de Las Mercedes Romero, Claudia Oviedo, Martin Vacchino, Patricia Galarza.   

Abstract

BACKGROUND: The emergence of Neisseria gonorrhoeae strains with decreased susceptibility to cephalosporins represents a major concern globally. The aim of this study was to examine the phenotypic and molecular characteristics of N. gonorrhoeae isolates with decreased susceptibility to ceftriaxone and cefixime in Argentina.
METHODS: A total of 1987 isolates were collected during 2009 and 2013. The susceptibility to penicillin G, tetracycline, ciprofloxacin, cefixime, ceftriaxone, and azithromycin was determined using the agar dilution method. The major extended-spectrum cephalosporin resistance determinants (penA, mtrR, and porB1b) were sequenced in 42 N. gonorrhoeae isolates that showed decreased susceptibility to ceftriaxone (minimum inhibitory concentration [MIC], 0.06-0.125 mg/L) and cefixime (MIC, 0.125-0.25 mg/L). Genotyping by N. gonorrhoeae multiantigen sequence typing (NG-MAST) was performed.
RESULTS: Between 2009 and 2013, there was a shift in the modal MICs for ceftriaxone. Among the 42 isolates exhibiting decreased susceptibility to ceftriaxone and cefixime, 95.2% were resistant to penicillin G, 95.2% to tetracycline, 97.6% to ciprofloxacin, and 33.3% to azithromycin. Thirty-five (83.3%) of the 42 isolates had a mosaic penA allele XXXIV, which has been previously associated with resistance to ceftriaxone and cefixime as well as treatment failures. The isolates that contained the mosaic penicillin-binding protein 2 (PBP2) XXXIV were associated with NG-MAST ST1407 or closely related genotypes.
CONCLUSIONS: In Argentina, N. gonorrhoeae isolates with decreased susceptibility to cefixime and ceftriaxone have now emerged, mostly due to the introduction of the internationally spread multidrug-resistant NG-MAST ST1407.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28499284     DOI: 10.1097/OLQ.0000000000000603

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  6 in total

Review 1.  World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts.

Authors:  Magnus Unemo; Monica M Lahra; Michelle Cole; Patricia Galarza; Francis Ndowa; Irene Martin; Jo-Anne R Dillon; Pilar Ramon-Pardo; Gail Bolan; Teodora Wi
Journal:  Sex Health       Date:  2019-09       Impact factor: 2.706

Review 2.  The antimicrobial resistance travel tool, an interactive evidence-based educational tool to limit antimicrobial resistance spread.

Authors:  Fabiana Arieti; Alessia Savoldi; Nithya Babu Rejendran; Marcella Sibani; Maela Tebon; Maria Diletta Pezzani; Anna Gorska; Teresa M Wozniak; Evelina Tacconelli
Journal:  J Travel Med       Date:  2022-07-14       Impact factor: 39.194

3.  Using the genetic characteristics of Neisseria gonorrhoeae strains with decreased susceptibility to cefixime to develop a molecular assay to predict cefixime susceptibility.

Authors:  Xiaomeng Deng; Lao-Tzu Allan-Blitz; Jeffrey D Klausner
Journal:  Sex Health       Date:  2019-09       Impact factor: 2.706

4.  Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016.

Authors:  Michaela J Day; Gianfranco Spiteri; Susanne Jacobsson; Neil Woodford; Andrew J Amato-Gauci; Michelle J Cole; Magnus Unemo
Journal:  BMC Infect Dis       Date:  2018-12-03       Impact factor: 3.090

5.  Surveillance systems to monitor antimicrobial resistance in Neisseria gonorrhoeae: a global, systematic review, 1 January 2012 to 27 September 2020.

Authors:  Nicholas A Medland; Ye Zhang; Praveena Gunaratnam; David A Lewis; Basil Donovan; David M Whiley; Rebecca J Guy; John M Kaldor
Journal:  Euro Surveill       Date:  2022-05

6.  Antimicrobial Resistance in Neisseria gonorrhoeae: Proceedings of the STAR Sexually Transmitted Infection-Clinical Trial Group Programmatic Meeting.

Authors:  Anthony D Cristillo; Claire C Bristow; Elizabeth Torrone; Jo-Anne Dillon; Robert D Kirkcaldy; Huan Dong; Yonatan H Grad; Robert A Nicholas; Peter A Rice; Kenneth Lawrence; David Oldach; William Maurice Shafer; Pei Zhou; Teodora E Wi; Sheldon R Morris; Jeffrey D Klausner
Journal:  Sex Transm Dis       Date:  2019-03       Impact factor: 2.830

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.